Skip to Content

'
Gabriel Lopez-Berestein, M.D.

Present Title & Affiliation

Primary Appointment

Professor of Medicine and Internist, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1976 Universidad de Navarra, Pamplona, Spain, MD, Immunology
1970 Universidad de Puerto Rico, Rio Piedras, PR, BS, Pre Med

Experience/Service

Academic Appointments

Adjunct Professor, Rice University, Houston, TX, 2006-present
Faculty, University of Texas Graduate School of Biomedical Sciences, Houston, TX, 2004-present
Adjunct Professor of Surgery, University of Puerto Rico School of Medicine, San Juan, PR, 2002-present
Professor, Department of Pharmacology, The University of Texas Medical School at Houston, Houston, TX, 1991-present
Professor of Biomedical Sciences, Department of Integrative Biology & Pharmacology, The University of Texas Health Science Center at Houston, Houston, TX, 1982-present

Administrative Appointments/Responsibilities

Executive Director, Pharmaceutical Development Center, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1998-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Shahzad MM, Lu C, Lee JW, Stone RL, Mitra R, Mangala LS, Lu Y, Baggerly KA, Danes CG, Nick AM, Halder J, Kim HS, Vivas-Mejia P, Landen CN, Lopez-Berestein G, Coleman RL, Sood AK. Dual targeting of EphA2 and FAK in ovarian carcinoma. Cancer Biol Ther 8(11). e-Pub 6/24/2009. PMID: 19395869.
2. Feng S, Agoulnik IU, Li Z, Han HD, Lopez-Berestein G, Sood A, Ittmann MM, Agoulnik AI. Relaxin/RXFP1 signaling in prostate cancer progression. Ann N Y Acad Sci 1160:379-80, 4/2009. PMID: 19416223.
3. Zhang HM, Chen SR, Cai YQ, Richardson TE, Driver LC, Lopez-Berestein G, Pan HL. Signaling mechanisms mediating muscarinic enhancement of GABAergic synaptic transmission in the spinal cord. Neuroscience 158(4):1577-88, 2/18/2009. e-Pub 12/7/2008. PMCID: PMC2646800.
4. Vivas-Mejía PE, Ozpolat B, Chen X, Lopez-Berestein G. Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Int J Cancer 125(2). e-Pub 2/2009. PMID: 19408305.
5. Ozpolat B, Akar U, Zorrilla-Calancha I, Vivas-Mejia P, Acevedo-Alvarez M, Lopez-Berestein G. Death-Associated Protein 5 (DAP5/p97/NAT1) Contributes to Retinoic Acid-Induced Granulocytic Differentiation and Arsenic Trioxide-Induced Apoptosis in Acute Promyelocytic Leukemia. Apoptosis 13(7):915-28, 2008. PMID: 18491231.

Last updated: 9/21/2009